Gastroduodenal Safety of Cyclooxygenase-2 Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2197-2206
Author(s):
James M. Scheiman
Regulation of B-Cell Activation by Complement Receptors CD21 and CD35
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1849-1860
Author(s):
Anna Erdei, Jozsef Prechl, Andrea Isaak and Eszter Molnar
Gene Expression Profiles in Human Autoimmune Disease
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1905-1917
Author(s):
Thomas M. Aune, Kevin Maas, Jason H. Moore and Nancy J. Olsen
FK506: Anti-Inflammatory Properties
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
2
Page:
260-264
Author(s):
Kiyoshi Migita and Katsumi Eguchi
Mechanisms Leading to Autoantibody Production: Link Between Inflammation and Autoimmunity
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
2
Page:
232-241
Author(s):
Hitoshi Ohmori and Naoki Kanayama
Expression and Function of the Leukocyte Integrins in Medicine
Journal:
Current Genomics
Volume:
4
Page:
527-542
Author(s):
John D. Noti
CCR1 Chemokine Receptor Antagonist
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1201-1208
Author(s):
Toshihiko Saeki and Akira Naya
Pharmacological Targets for the Inhibition of Neurogenic Inflammation
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
2
Page:
191-218
Author(s):
Zsuzsanna Helyes, Erika Pinter, Jozsef Nemeth and Janos Szolcsanyi
The Neuropeptides VIP / PACAP and T Cells: Inhibitors or Activators?
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
997-1004
Author(s):
Doina Ganea and Mario Delgado
Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1095-1126
Author(s):
Peter C. Taylor